There were no SNPs in ERAP1 (Table 2) or ERAP2 (Table 3) that exhibited a significantly different distribution between the CIN and control groups or between the CIN and cervical cancer groups after Bonferroni correction (P > 0.0045). This evidence concerns the gene ERAP2 and cervical carcinoma.